Revenue (Quarterly) Chart

View Revenue (Quarterly) for MNICF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
May 31, 2026 52.25M
February 28, 2026 53.09M
November 30, 2025 51.77M
August 31, 2025 52.53M
May 31, 2025 51.18M
February 28, 2025 46.49M
November 30, 2024 51.44M
August 31, 2024 44.87M
May 31, 2024 50.24M
February 29, 2024 46.33M
November 30, 2023 47.73M
August 31, 2023 41.88M
May 31, 2023 48.17M
February 28, 2023 44.58M
November 30, 2022 42.37M
August 31, 2022 41.29M
May 31, 2022 41.62M
February 28, 2022 42.94M
November 30, 2021 42.05M
August 31, 2021 38.66M
May 31, 2021 42.52M
February 28, 2021 39.35M
November 30, 2020 39.96M
August 31, 2020 31.24M
May 31, 2020 31.50M
Date Value
February 29, 2020 37.72M
November 30, 2019 40.17M
August 31, 2019 42.30M
May 31, 2019 42.30M
February 28, 2019 38.81M
November 30, 2018 42.59M
August 31, 2018 46.33M
May 31, 2018 49.16M
February 28, 2018 44.81M
November 30, 2017 41.98M
August 31, 2017 43.01M
May 31, 2017 37.44M
February 28, 2017 36.36M
November 30, 2016 38.52M
August 31, 2016 42.72M
May 31, 2016 39.05M
February 29, 2016 32.25M
November 30, 2015 33.12M
August 31, 2015 35.30M
May 31, 2015 27.82M
February 28, 2015 27.25M
November 30, 2014 26.23M
August 31, 2014 29.45M
May 31, 2014 28.91M
February 28, 2014 26.96M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Terumo Corp. 1.957B
Nipro Corp. 1.051B
HOYA Corp. 1.605B
Nakanishi, Inc. 155.29M
Abbott Laboratories 12.59B